Quarterly report [Sections 13 or 15(d)]

Consolidated Balance Sheets

v3.25.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
 [1]
Current Assets:    
Cash and cash equivalents $ 32,516 $ 35,469
Restricted cash 623 742
Accounts receivable (net of allowance for credit losses of $19 and $23, respectively) 54,757 58,217
Inventories 53,390 49,914
Derivative instruments 3,602 3,313
Other current assets 6,035 5,463
Total current assets 150,923 153,118
Property and equipment, net 203,528 214,742
Other Assets:    
Right of use operating lease assets, net 18,001 20,553
Intangible assets, net 7,730 4,509
Other assets 8,292 8,516
Total other assets 34,023 33,578
Total Assets 388,474 401,438
Current Liabilities:    
Accounts payable 15,521 20,369
Accrued liabilities 16,191 24,214
Current portion – operating leases 5,140 4,851
Derivative instruments 108 1,177
Other current liabilities 5,459 7,193
Total current liabilities 42,419 57,804
Long-term debt, net 100,598 92,904
Operating leases, net of current portion 13,955 16,913
Other liabilities 9,100 8,754
Total Liabilities 166,072 176,375
Commitments and Contingencies (Note 6)
Stockholders’ Equity:    
Preferred stock, $0.001 par value; 10,000 shares authorized; Series A: 1,684 shares authorized; no shares issued and outstanding as of September 30, 2025 and December 31, 2024; Series B: 1,581 shares authorized; 927 shares issued and outstanding as of September 30, 2025 and December 31, 2024; liquidation preference of $18,075 as of September 30, 2025 1 1
Common stock value 77 77
Additional paid-in capital 1,050,929 1,044,176
Accumulated other comprehensive income 4,975 4,975
Accumulated deficit (833,580) (824,166)
Total Stockholders’ Equity 222,402 225,063
Total Liabilities and Stockholders’ Equity 388,474 401,438
Non-voting Common Stock    
Stockholders’ Equity:    
Common stock value
[1] Amounts derived from the audited consolidated financial statements for the year ended December 31, 2024.